Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices 50139 

ACTION: Notice of meeting. 

SUMMARY: As required by the Federal 

Advisory Committee Act, the U.S. 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the COVID–19 Health Equity Task 

Force (Task Force) will hold a virtual 

meeting on September 30, 2021. The 

purpose of this meeting is to present 

and vote on the final recommendations 

for mitigating inequities caused or 

exacerbated by the COVID–19 pandemic 

and for preventing such inequities in 

the future. This meeting is open to the 

public and will be live-streamed at 

www.hhs.gov/live. Information about the 

meeting will be posted on the HHS 

Office of Minority Health website: 

www.minorityhealth.hhs.gov/ 

healthequitytaskforce/ prior to the 

meeting. 

DATES: The Task Force meeting will be 

held on Thursday, September 30, 2021, 

from 2 p.m. to approximately 6 p.m. ET 

(date and time are tentative and subject 

to change). The confirmed time and 

agenda will be posted on the COVID–19 

Health Equity Task Force web page: 

www.minorityhealth.hhs.gov/ 

healthequitytaskforce/ when this 

information becomes available. 

FOR FURTHER INFORMATION CONTACT: 

Samuel Wu, Designated Federal Officer 

for the Task Force; Office of Minority 

Health, Department of Health and 

Human Services, Tower Building, 1101 

Wootton Parkway, Suite 100, Rockville, 

Maryland 20852. Phone: 240–453–6173; 

email: COVID19HETF@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The COVID–19 Health 

Equity Task Force (Task Force) was 

established by Executive Order 13995, 

dated January 21, 2021. The Task Force 

is tasked with providing specific 

recommendations to the President, 

through the Coordinator of the COVID– 

19 Response and Counselor to the 

President (COVID–19 Response 

Coordinator), for mitigating the health 

inequities caused or exacerbated by the 

COVID–19 pandemic and for preventing 

such inequities in the future. The Task 

Force shall submit a final report to the 

COVID–19 Response Coordinator 

addressing any ongoing health 

inequities faced by COVID–19 survivors 

that may merit a public health response, 

describing the factors that contributed to 

disparities in COVID–19 outcomes, and 

recommending actions to combat such 

disparities in future pandemic 

responses. 

The meeting is open to the public and 

will be live-streamed at www.hhs.gov/ 

live. No registration is required. A 

public comment session will be held 

during the meeting. Pre-registration is 

required to provide public comment 

during the meeting. To pre-register, 

please send an email to 

COVID19HETF@hhs.gov and include 

your name, title, and organization by 

close of business on Friday, September 

24, 2021. Comments will be limited to 

no more than three minutes per speaker 

and should be pertinent to the meeting 

discussion. Individuals are encouraged 

to provide a written statement of any 

public comment(s) for accurate minutetaking purposes. If you decide you 

would like to provide public comment 

but do not pre-register, you may submit 

your written statement by emailing 

COVID19HETF@hhs.gov no later than 

close of business on Thursday, October 

7, 2021. Individuals who plan to attend 

and need special assistance, such as 

sign language interpretation or other 

reasonable accommodations, should 

contact: COVID19HETF@hhs.gov and 

reference this meeting. Requests for 

special accommodations should be 

made at least 10 business days prior to 

the meeting. 

Dated: September 1, 2021. 

Samuel Wu, 

Designated Federal Officer, COVID–19 Health 

Equity Task Force. 

[FR Doc. 2021–19322 Filed 9–3–21; 8:45 am] 

BILLING CODE 4150–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group; Function, Integration, and 

Rehabilitation Sciences Study Section. 

Date: October 22, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2137D, 

Bethesda, MD 20892 (Video-Assisted 

Meeting). 

Contact Person: Helen Huang, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Eunice Kennedy Shriver Institute of 

Child Health and Human Development, 

National Institutes of Health, 6710B 

Rockledge Drive, Room 2137D, Bethesda, MD 

20892, (301) 435–8207, helen.huang@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: September 2, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–19354 Filed 9–3–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group Neurogenesis and Cell Fate 

Study Section. 

Date: October 6–7, 2021. 

Time: 11:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joanne T. Fujii, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4184, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1178, fujiij@csr.nih.gov. 


sradovich on DSKJLST7X2PROD with NOTICES
50140 Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices 

Name of Committee: Cell Biology 

Integrated Review Group Nuclear and 

Cytoplasmic Structure/Function and 

Dynamics Study Section. 

Date: October 7–8, 2021. 

Time: 11:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jessica Smith, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 402–3717, jessica.smith6@

nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group Neurobiology of 

Pain and Itch Study Section. 

Date: October 12–13, 2021. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: M. Catherine Bennett, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1766, bennettc3@csr.nih.gov. 

Name of Committee: Oncology 1-Basic 

Translational Integrated Review Group 

Tumor Progression and Metastasis Study 

Section. 

Date: October 13–14, 2021. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Rolf Jakobi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6187, 

MSC 7806, Bethesda, MD 20892, 301–495– 

1718 jakobir@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 31, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–19153 Filed 9–3–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; P41 NCBIB Review 

B–SEP. 

Date: October 26–28, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Democracy II, 6707 Democracy Blvd., 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ruixia Zhou, Ph.D., 

Scientific Review Officer, National Institute 

of Biomedical Imaging and Bioengineering, 

National Institutes of Health, 6707 

Democracy Blvd., Suite 957, Bethesda, MD 

20892, (301) 496–4773, zhour@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, National Institute of 

Biomedical Imaging and Bioengineering, 

National Institutes of Health, HHS) 

Dated: August 31, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–19155 Filed 9–3–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; The Genetic Testing Registry 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995 to provide 

opportunity for public comment on 

proposed data collection projects, the 

National Institutes of Health (NIH), 

Office of the Director (OD) will publish 

periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Taunton Paine, Director, 

Division of Scientific Data Sharing 

Policy, Office of Science Policy, NIH, 

6705 Rockledge Dr., Suite 631, 

Bethesda, MD 20892, or call non-toll 

free number (301) 496–9838, or Email 

your request, including your address to: 

SciencePolicy@mail.nih.gov. Formal 

requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Proposed Collection Title: The 

Genetic Testing Registry, 0925–0651, 

Expiration Date 11/30/21— 

EXTENSION, Office of the Director 

(OD), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: Clinical laboratory tests are 

available for more than 18,000 genetic 

conditions. The Genetic Testing Registry 

(GTR) provides a centralized, online 

location for test developers, 

manufacturers, and researchers to 


sradovich on DSKJLST7X2PROD with NOTICES